A Phase II, Multicentre, Multinational, Randomised, Assessor-Blind Trial to Investigate the Efficacy and Safety of Various Dosages of FSH-GEX in Comparison With 150 IU Gonal-f in Women Undergoing ICSI Treatment.

Trial Profile

A Phase II, Multicentre, Multinational, Randomised, Assessor-Blind Trial to Investigate the Efficacy and Safety of Various Dosages of FSH-GEX in Comparison With 150 IU Gonal-f in Women Undergoing ICSI Treatment.

Completed
Phase of Trial: Phase II

Latest Information Update: 31 Jul 2014

At a glance

  • Drugs Follicle-stimulating hormone glyco-optimised (Primary) ; Follitropin alfa
  • Indications Female infertility
  • Focus Biomarker; Pharmacodynamics
  • Sponsors Glycotope
  • Most Recent Events

    • 26 Mar 2014 Status changed from active, no longer recruiting to completed, as per European Clinical Trials Database record.
    • 19 Jun 2013 The trial is expected to report at the beginning of the fourth quarter of 2013, according to a Glycotope media release.
    • 19 Jun 2013 Status changed from recruiting to active, no longer recruiting, according to a Glycotope media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top